NASDAQ:VLRX - Valeritas News Headlines

$2.67
-0.03 (-1.11 %)
(As of 07/22/2019 07:37 AM ET)
Today's Range
$2.6099
Now: $2.67
$2.7351
50-Day Range
$2.56
MA: $3.04
$3.78
52-Week Range
$2.10
Now: $2.67
$33.80
Volume241,768 shs
Average Volume882,092 shs
Market Capitalization$14.18 million
P/E RatioN/A
Dividend YieldN/A
Beta1.79

Headlines

Valeritas (NASDAQ VLRX) News Headlines

Source:
DateHeadline
BRIEF-Valeritas Says Entered Into Confidential Settlement Agreement With Roche Diabetes Care Inc - ReutersBRIEF-Valeritas Says Entered Into Confidential Settlement Agreement With Roche Diabetes Care Inc - Reuters
www.reuters.com - July 18 at 11:25 AM
Mid-Day Market Update: Crude Oil Up Over 3%; Valeritas Shares Spike Higher - BenzingaMid-Day Market Update: Crude Oil Up Over 3%; Valeritas Shares Spike Higher - Benzinga
www.benzinga.com - July 11 at 10:16 AM
Brokers Set Expectations for Valeritas Holdings Incs Q2 2019 Earnings (NASDAQ:VLRX)Brokers Set Expectations for Valeritas Holdings Inc's Q2 2019 Earnings (NASDAQ:VLRX)
www.americanbankingnews.com - July 11 at 7:31 AM
Mid-Afternoon Market Update: Dow Rises Over 100 Points; Levi Strauss Shares Plummet - BenzingaMid-Afternoon Market Update: Dow Rises Over 100 Points; Levi Strauss Shares Plummet - Benzinga
www.benzinga.com - July 10 at 4:24 PM
OncoSec Medical and Trinity Biotech among healthcare gainers; Amneal Pharmaceuticals leads the losers - Seeking AlphaOncoSec Medical and Trinity Biotech among healthcare gainers; Amneal Pharmaceuticals leads the losers - Seeking Alpha
seekingalpha.com - July 10 at 4:24 PM
Mid-Morning Market Update: Markets Open Higher; MSC Industrial Misses Q3 Expectations - BenzingaMid-Morning Market Update: Markets Open Higher; MSC Industrial Misses Q3 Expectations - Benzinga
www.benzinga.com - July 10 at 10:42 AM
Thinking about buying stock in Aurora Cannabis, Camber Energy, McDermott International, Vislink Technologies, or Valeritas Holdings? - PRNewswireThinking about buying stock in Aurora Cannabis, Camber Energy, McDermott International, Vislink Technologies, or Valeritas Holdings? - PRNewswire
www.prnewswire.com - July 10 at 10:42 AM
What Caused The Opening Gap In Valeritas? - BenzingaWhat Caused The Opening Gap In Valeritas? - Benzinga
www.benzinga.com - July 10 at 10:42 AM
Valeritas up 42% premarket as managed care providers pick up V-Go - Seeking AlphaValeritas up 42% premarket as managed care providers pick up V-Go - Seeking Alpha
seekingalpha.com - July 10 at 10:42 AM
Valeritas Insulin Device For Diabetics Accepted Under Managed Formulary - BenzingaValeritas Insulin Device For Diabetics Accepted Under Managed Formulary - Benzinga
www.benzinga.com - July 10 at 10:42 AM
Head to Head Review: Valeritas (NASDAQ:VLRX) versus PAVmed (NASDAQ:PAVM)Head to Head Review: Valeritas (NASDAQ:VLRX) versus PAVmed (NASDAQ:PAVM)
www.americanbankingnews.com - July 10 at 10:20 AM
Valeritas (VLRX) V-Go Wearable Insulin Delivery device has been recently adopted on managed care formularies - StreetInsider.comValeritas (VLRX) V-Go Wearable Insulin Delivery device has been recently adopted on managed care formularies - StreetInsider.com
www.streetinsider.com - July 9 at 4:31 PM
Oppenheimer Increases Valeritas (NASDAQ:VLRX) Price Target to $12.00Oppenheimer Increases Valeritas (NASDAQ:VLRX) Price Target to $12.00
www.americanbankingnews.com - July 9 at 2:02 PM
Valeritas V-Go® Wearable Insulin Delivery Device Demonstrates Economic Advantages Compared to Multiple Daily Injection Therapy for Insulin Dependent Type 2 Diabetes Population - NasdaqValeritas' V-Go® Wearable Insulin Delivery Device Demonstrates Economic Advantages Compared to Multiple Daily Injection Therapy for Insulin Dependent Type 2 Diabetes Population - Nasdaq
www.nasdaq.com - July 9 at 10:51 AM
Valeritas’ V-Go® Wearable Insulin Delivery Device Demonstrates Economic Advantages Compared to Multiple Daily Injection Therapy for Insulin Dependent Type 2 Diabetes Population - Yahoo FinanceValeritas’ V-Go® Wearable Insulin Delivery Device Demonstrates Economic Advantages Compared to Multiple Daily Injection Therapy for Insulin Dependent Type 2 Diabetes Population - Yahoo Finance
finance.yahoo.com - July 8 at 10:29 AM
Valeritas’ V-Go® Wearable Insulin Delivery Device Demonstrates Economic Advantages Compared to Multiple Daily Injection Therapy for Insulin Dependent Type 2 Diabetes PopulationValeritas’ V-Go® Wearable Insulin Delivery Device Demonstrates Economic Advantages Compared to Multiple Daily Injection Therapy for Insulin Dependent Type 2 Diabetes Population
finance.yahoo.com - July 8 at 10:29 AM
Valeritas files U.S. application for use of regular insulin with V-Go - Seeking AlphaValeritas files U.S. application for use of regular insulin with V-Go - Seeking Alpha
seekingalpha.com - June 28 at 10:31 AM
Form 8-K Valeritas Holdings Inc. For: Jun 27 - StreetInsider.comForm 8-K Valeritas Holdings Inc. For: Jun 27 - StreetInsider.com
www.streetinsider.com - June 28 at 10:31 AM
Valeritas Files Special 510(k) with FDA for Labeling Change to Include the Use of Regular Human Insulin In V-Go® Wearable Insulin Delivery Device - GlobeNewswireValeritas Files Special 510(k) with FDA for Labeling Change to Include the Use of Regular Human Insulin In V-Go® Wearable Insulin Delivery Device - GlobeNewswire
www.globenewswire.com - June 27 at 10:43 AM
Valeritas Files Special 510(k) with FDA for Labeling Change to Include the Use of Regular Human Insulin In V-Go® Wearable Insulin Delivery DeviceValeritas Files Special 510(k) with FDA for Labeling Change to Include the Use of Regular Human Insulin In V-Go® Wearable Insulin Delivery Device
finance.yahoo.com - June 27 at 10:43 AM
Valeritas Announces Milestone of 20 Million V-Go® Insulin Delivery Devices Sold - GlobeNewswireValeritas Announces Milestone of 20 Million V-Go® Insulin Delivery Devices Sold - GlobeNewswire
globenewswire.com - June 26 at 10:54 AM
Valeritas Announces Milestone of 20 Million V-Go® Insulin Delivery Devices Sold - Yahoo FinanceValeritas Announces Milestone of 20 Million V-Go® Insulin Delivery Devices Sold - Yahoo Finance
finance.yahoo.com - June 24 at 6:42 PM
Valeritas Announces Milestone of 20 Million V-Go® Insulin Delivery Devices SoldValeritas Announces Milestone of 20 Million V-Go® Insulin Delivery Devices Sold
finance.yahoo.com - June 24 at 6:42 PM
Valeritas up 5% on positive V-Go data - Valeritas Holdings, Inc. (NASDAQ:VLRX) - Seeking AlphaValeritas up 5% on positive V-Go data - Valeritas Holdings, Inc. (NASDAQ:VLRX) - Seeking Alpha
seekingalpha.com - June 10 at 4:36 PM
Valeritas V-Go® Wearable Insulin Delivery Device Demonstrates a Reduction in A1c Levels by 1.3 when Intensifying from a Basal Insulin Regimen to Basal-Bolus Delivery - GlobeNewswireValeritas' V-Go® Wearable Insulin Delivery Device Demonstrates a Reduction in A1c Levels by 1.3 when Intensifying from a Basal Insulin Regimen to Basal-Bolus Delivery - GlobeNewswire
www.globenewswire.com - June 10 at 11:31 AM
Valeritas’ V-Go® Wearable Insulin Delivery Device Demonstrates a Reduction in A1c Levels by 1.3 when Intensifying from a Basal Insulin Regimen to Basal-Bolus DeliveryValeritas’ V-Go® Wearable Insulin Delivery Device Demonstrates a Reduction in A1c Levels by 1.3 when Intensifying from a Basal Insulin Regimen to Basal-Bolus Delivery
finance.yahoo.com - June 10 at 11:31 AM
Valeritas Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Yahoo FinanceValeritas Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Yahoo Finance
finance.yahoo.com - May 31 at 4:57 PM
Valeritas affirms guidance; shares up 7% premarket - Seeking AlphaValeritas affirms guidance; shares up 7% premarket - Seeking Alpha
seekingalpha.com - May 29 at 10:36 AM
Valeritas to Participate in the American Diabetes Association’s 79th Scientific Sessions; Company Reiterates Second Quarter and Full-Year 2019 Revenue GuidanceValeritas to Participate in the American Diabetes Association’s 79th Scientific Sessions; Company Reiterates Second Quarter and Full-Year 2019 Revenue Guidance
finance.yahoo.com - May 29 at 10:36 AM
American Diabetes Association Includes “Disposable Patch-Like Device,” such as V-Go® from Valeritas, in the ADA Standards of Medical Care in Diabetes - 2019 - GlobeNewswireAmerican Diabetes Association Includes “Disposable Patch-Like Device,” such as V-Go® from Valeritas, in the ADA Standards of Medical Care in Diabetes - 2019 - GlobeNewswire
www.globenewswire.com - May 28 at 4:29 PM
American Diabetes Association Includes “Disposable Patch-Like Device,” such as V-Go® from Valeritas, in the ADA Standards of Medical Care in Diabetes - 2019 - Yahoo FinanceAmerican Diabetes Association Includes “Disposable Patch-Like Device,” such as V-Go® from Valeritas, in the ADA Standards of Medical Care in Diabetes - 2019 - Yahoo Finance
finance.yahoo.com - May 28 at 10:37 AM
American Diabetes Association Includes “Disposable Patch-Like Device,” such as V-Go® from Valeritas, in the ADA Standards of Medical Care in Diabetes - 2019American Diabetes Association Includes “Disposable Patch-Like Device,” such as V-Go® from Valeritas, in the ADA Standards of Medical Care in Diabetes - 2019
finance.yahoo.com - May 28 at 10:37 AM
Valeritas up 38% premarket on positive V-Go data - Seeking AlphaValeritas up 38% premarket on positive V-Go data - Seeking Alpha
seekingalpha.com - May 23 at 10:39 AM
Valeritas’ V-Go® Demonstrates Positive Impact in Diabetes Quality Performance Measures in an Older Adult Population - Yahoo FinanceValeritas’ V-Go® Demonstrates Positive Impact in Diabetes Quality Performance Measures in an Older Adult Population - Yahoo Finance
finance.yahoo.com - May 22 at 10:43 AM
Valeritas’ V-Go® Demonstrates Positive Impact in Diabetes Quality Performance Measures in an Older Adult PopulationValeritas’ V-Go® Demonstrates Positive Impact in Diabetes Quality Performance Measures in an Older Adult Population
finance.yahoo.com - May 22 at 10:43 AM
Valeritas Holdings Inc.Valeritas Holdings Inc.
www.barrons.com - May 20 at 2:38 PM
Valeritas Announces Reverse Stock Split Nasdaq:VLRX - GlobeNewswireValeritas Announces Reverse Stock Split Nasdaq:VLRX - GlobeNewswire
globenewswire.com - May 18 at 4:10 PM
Valeritas (VLRX) Reports 1-for-20 Reverse Share Split - StreetInsider.comValeritas (VLRX) Reports 1-for-20 Reverse Share Split - StreetInsider.com
www.streetinsider.com - May 17 at 10:30 AM
Valeritas Exhibits at Taking Control of Your Diabetes Conferences - GlobeNewswireValeritas Exhibits at Taking Control of Your Diabetes Conferences - GlobeNewswire
globenewswire.com - May 14 at 11:13 AM
Valeritas Exhibits at Taking Control of Your Diabetes ConferencesValeritas Exhibits at Taking Control of Your Diabetes Conferences
finance.yahoo.com - May 13 at 10:50 AM
Valeritas Holdings, Inc. (VLRX) CEO John Timberlake on Q1 2019 Results - Earnings Call Transcript - Seeking AlphaValeritas Holdings, Inc. (VLRX) CEO John Timberlake on Q1 2019 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 11 at 10:54 AM
Edited Transcript of VLRX earnings conference call or presentation 9-May-19 8:30pm GMT - Yahoo FinanceEdited Transcript of VLRX earnings conference call or presentation 9-May-19 8:30pm GMT - Yahoo Finance
finance.yahoo.com - May 10 at 4:51 PM
Edited Transcript of VLRX earnings conference call or presentation 9-May-19 8:30pm GMTEdited Transcript of VLRX earnings conference call or presentation 9-May-19 8:30pm GMT
finance.yahoo.com - May 10 at 4:51 PM
Valeritas Holdings, Inc. (VLRX) Reports Q1 Loss, Tops Revenue EstimatesValeritas Holdings, Inc. (VLRX) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 10 at 10:51 AM
Valeritas Announces First Quarter 2019 Financial Results and Updates Full Year 2019 Revenue GuidanceValeritas Announces First Quarter 2019 Financial Results and Updates Full Year 2019 Revenue Guidance
finance.yahoo.com - May 9 at 4:58 PM
Valeritas Expects First Quarter Revenue of $6.4 million - GlobeNewswireValeritas Expects First Quarter Revenue of $6.4 million - GlobeNewswire
www.globenewswire.com - May 4 at 10:53 AM
Will Valeritas Holdings, Inc. (VLRX) Report Negative Earnings Next Week? What You Should Know - NasdaqWill Valeritas Holdings, Inc. (VLRX) Report Negative Earnings Next Week? What You Should Know - Nasdaq
www.nasdaq.com - May 3 at 5:01 PM
Will Valeritas Holdings, Inc. (VLRX) Report Negative Earnings Next Week? What You Should Know - Yahoo FinanceWill Valeritas Holdings, Inc. (VLRX) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
finance.yahoo.com - May 2 at 4:59 PM
Form 8-K Valeritas Holdings Inc. For: May 02 - StreetInsider.comForm 8-K Valeritas Holdings Inc. For: May 02 - StreetInsider.com
www.streetinsider.com - May 2 at 4:59 PM
Will Valeritas Holdings, Inc. (VLRX) Report Negative Earnings Next Week? What You Should KnowWill Valeritas Holdings, Inc. (VLRX) Report Negative Earnings Next Week? What You Should Know
finance.yahoo.com - May 2 at 4:59 PM
This page was last updated on 7/22/2019 by MarketBeat.com Staff

Featured Article: Trade Deficit

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel